BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Ajinomoto Althea Inc. 

11040 Roselle Street

San Diego  California  92121  U.S.A.
Phone: 858-882-0123 Fax: 858-882-0133


SEARCH JOBS



Ajinomoto Althea, located in San Diego, CA, is a contract development and manufacturing organization that specializes in cGMP manufacturing, analytical development, aseptic filling into vials & syringes, and protein delivery technology for recombinant protein and parenteral products. In a single location, Althea has the capacity to meet your early-stage and commercial requirements.

Key Services:

• Cell Line Development
• Process Development
• cGMP Protein & DNA Plasmid Production
• Analytical Method Development
• Lyophilization Cycle Development
• Sterile Vial Filling
• Sterile Syringe Filling

Protein Formulation Technology - Crystalomics™

• High Concentration Formulations
• Sustained Release Formulations
• Proven Technology
• Proven cGMP Manufacturability at Scale

Since its founding in 1998, Althea's manufacturing facilities have been inspected by the FDA in 2005, 2008, 2011 (2), 2012 & 2013, and by over 30 different QPs. To-date, Althea’s cGMP facilities have produced >300 cell banks, >160 cGMP protein & plasmid DNA lots, and >1,700 cGMP fill & finish lots. Althea has the experience, expertise, capacity, and flexibility to serve as your strategic partner for your drug development and manufacturing needs.


 Key Statistics


Email: info@altheatech.com
Ownership: Private

Web Site: Ajinomoto Althea Inc.
Employees:
Symbol: 
 









 Company News
Ajinomoto Completes Acquisition of Althea Technologies, Inc. 4/5/2013 9:00:05 AM
Ajinomoto Agrees to Acquire Althea Technologies, Inc. for $175 Million 3/6/2013 7:37:04 AM
Althea Technologies, Inc. & Profectus BioSciences, Inc. Sign Manufacturing Agreement for Plasmid DNA Production 2/26/2013 9:32:33 AM
Pfenex Inc. Awards Althea Technologies, Inc. a Contract for cGMP Manufacturing of Circumsporozoite Protein From Plasmodium Falciparum, a Key Malaria Antigen 10/24/2012 10:30:21 AM
Althea Technologies, Inc. Announces Expanded Roles for Key Executives 9/24/2012 10:41:50 AM
Althea Technologies, Inc. Appoints Dr. Dennis Fenton as Chairman of Its Scientific Advisory Board 6/19/2012 10:35:24 AM
Althea Technologies, Inc. Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing 5/2/2012 10:33:47 AM
Allena Pharmaceuticals, Inc. Licenses Worldwide Rights to Hyperoxaluria Portfolio from Althea Technologies, Inc. 3/28/2012 7:28:53 AM
Althea Technologies, Inc. Appoints Martha J. Demski as Senior Vice President and Chief Financial Officer 9/8/2011 5:55:58 AM
Althea Technologies, Inc. Hosts Health and Wellness Week 8/11/2011 6:14:37 AM
12345